The movement disorders can be prominent and in 14% of anti-IgLON5 disease patients, initial symptoms may suggest a diagnosis of progressive supranuclear palsy (PSP) [3, 6, 7]. The gene discussed is IGLON5; the disease is progressive supranuclear palsy.